🇯🇵 Zerbaxa in Japan

PMDA authorised Zerbaxa on 8 January 2019

Marketing authorisation

PMDA — authorised 8 January 2019

  • Marketing authorisation holder: MSD K.K.
  • Status: approved

Zerbaxa in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in Japan

Frequently asked questions

Is Zerbaxa approved in Japan?

Yes. PMDA authorised it on 8 January 2019.

Who is the marketing authorisation holder for Zerbaxa in Japan?

MSD K.K. holds the Japanese marketing authorisation.